Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A spanish matched cohort multicenter study

Annals of Surgery

Volumn 259, Issue 5, 2014, Pages 944-952

  Sapisochin, G ^a   De Lope, C Rodríguez ^b   Gastaca, M ^c   De Urbina, J Ortiz ^c   Lopez Andujar R ^d   Palacios, F ^d   Ramos, E ^e   Fabregat, J ^e   Castroagudin J F ^f   Varo, E ^f   Pons, J A ^g   Parrilla, P ^h   Gonzalez Dieguez M L ⁱ   Rodriguez, M ⁱ   Otero, A ^j   Vazquez, M A ^j   Zozaya, G ^k   Herrero, J I ^g   Antolin, G Sanchez ^l   Perez, B ^l   Ciria, R ^m   Rufian, S ^m   Fundora, Y ⁿ   Ferron, J A ⁿ   Guiberteau, A ^o   Blanco, G ^o   Varona, M A ^p   Barrera, M A ^p   Suarez, M A ^q   Santoyo, J ^q   Bruix, J ^b   Charco, R ^a   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j UNIVERSITY OF A CORUÑA   (Spain)

^k UNIVERSITY CLINIC OF NAVARRA   (Spain)

^l HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^o HOSPITAL INFANTA CRISTINA   (Spain)

^p HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^q HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

more..

Author keywords

hepatocellular carcinoma; intrahepatic cholangiocarcinoma; liver transplantation; mixed hepatocellular cholangiocarcinoma; outcome

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATOCELLULAR CHOLANGIOCARCINOMA; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899067670     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000494     Document Type: Article

References (34)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379: 1245-1255.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996; 334: 693-699.
3. Shaib YH, El-Serag H. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004; 24: 115-125.
4. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008; 48: 308-321.
5. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000; 69: 1633-1637.
6. Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J Hepatobiliary Pancreat Surg. 2003; 10: 282-287.
7. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg. 1993; 166: 768-771; discussion 771-772.
8. Ali JM, Bonomo L, Brais R, et al. Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation. Transplantation. 2011; 91: 1392-1397.
9. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl. 2005; 11: 1412-1416.
10. Jarnagin WR, Weber S, Tickoo SF, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical and prognostic factors. Cancer. 2002; 94: 2040-2046.
11. Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol. 2010; 25: 1485-1492.
12. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949; 25: 647-655.
13. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellularcholangiocarcinoma: a histologic and immuno-histochemical study. Cancer. 1985; 55: 124-135.
14. Vilana R, Forner A, Bianchi L, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010; 51: 2020-2029.
15. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology. 2009; 50: 791-798.
16. Sapisochin G, Fidelman N, Roberts JP, et al. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011; 17: 934-942.
17. Yin X, Zhang BH, Qiu SJ, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg. Oncol. 2012; 19: 2869-2876.
18. Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2011; 45: 69-75.
19. Panjala C, Senecal DL, BridgesMD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010; 10: 1263-1267.
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1236.
21. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001; 35: 421-430.
22. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transpl. 2007; 7: 2587-2596.
23. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer. 1954; 1: 462-503.
24. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012; 57: 69-76.
25. Mazzaferro V, Llovet JM, Miceli R, et al; Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009; 10: 35-43.
26. Sapisochin G, Castells L, Dopazo C, et al. Single HCC in cirrhotic patients. Liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg. Oncol. 2013; 20: 1194-1202.
27. Robles R, Figueras J, Turrión VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004; 239: 265-271.
28. Chok KS, Ng KK, Cheung TT, et al. An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg. 2009; 33: 1916-1921.
29. Park SJ, Freise CE, Hirose R, et al. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant. 2012; 26: E359-E364.
30. Onaca N, Davis GL, Jennings LW, et al. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl. 2009; 15: 574-580.
31. Samuel D, Colombo M, El-Serag H, et al. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transpl. 2011; 17: S6-S13.
32. Clavien PA, Lesurtel M, Bossuyt PM, et al., OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012; 13: e11-e22.
33. Ghittoni G, Caturelli E, Rossi S. Noninvasive diagnostic criteria for hepatocellular carcinoma: a boat that leaks like a sieve. Hepatology. 2010; 52: 1515-1516; author reply 1516-1517.
34. Malouf G, Falissard B, Azoulay D, et al. Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts? J Clin Pathol. 2009; 62: 519-524.